BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22192488)

  • 1. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
    Gebre T; Ayele B; Zerihun M; Genet A; Stoller NE; Zhou Z; House JI; Yu SN; Ray KJ; Emerson PM; Keenan JD; Porco TC; Lietman TM; Gaynor BD
    Lancet; 2012 Jan; 379(9811):143-51. PubMed ID: 22192488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
    House JI; Ayele B; Porco TC; Zhou Z; Hong KC; Gebre T; Ray KJ; Keenan JD; Stoller NE; Whitcher JP; Gaynor BD; Emerson PM; Lietman TM
    Lancet; 2009 Mar; 373(9669):1111-8. PubMed ID: 19329003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
    Melese M; Alemayehu W; Lakew T; Yi E; House J; Chidambaram JD; Zhou Z; Cevallos V; Ray K; Hong KC; Porco TC; Phan I; Zaidi A; Gaynor BD; Whitcher JP; Lietman TM
    JAMA; 2008 Feb; 299(7):778-84. PubMed ID: 18285589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial.
    Aragie S; Wittberg DM; Tadesse W; Dagnew A; Hailu D; Chernet A; Melo JS; Aiemjoy K; Haile M; Zeru T; Tadesse Z; Gwyn S; Martin DL; Arnold BF; Freeman MC; Nash SD; Callahan EK; Porco TC; Lietman TM; Keenan JD
    Lancet Glob Health; 2022 Jan; 10(1):e87-e95. PubMed ID: 34919861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
    N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics for trachoma.
    Evans JR; Solomon AW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001860. PubMed ID: 21412875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL; Arullendran P; Whittle HC; Mabey DC
    Lancet; 1993 Aug; 342(8869):453-6. PubMed ID: 8102427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
    Lietman TM; Ayele B; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Nash SD; Porco TC; Keenan JD; Oldenburg CE
    Am J Ophthalmol; 2020 Jun; 214():143-150. PubMed ID: 32171768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical ocular antibiotics induce bacterial resistance at extraocular sites.
    Gaynor BD; Chidambaram JD; Cevallos V; Miao Y; Miller K; Jha HC; Bhatta RC; Chaudhary JS; Osaki Holm S; Whitcher JP; Holbrook KA; Fry AM; Lietman TM
    Br J Ophthalmol; 2005 Sep; 89(9):1097-9. PubMed ID: 16113356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
    Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
    Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for ocular chlamydia after three mass azithromycin distributions.
    Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
    West SK; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Foster A; Bailey RL; Mabey DC
    Lancet; 2005 Oct; 366(9493):1296-300. PubMed ID: 16214600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
    Melese M; Chidambaram JD; Alemayehu W; Lee DC; Yi EH; Cevallos V; Zhou Z; Donnellan C; Saidel M; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2004 Aug; 292(6):721-5. PubMed ID: 15304470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
    Harding-Esch EM; Sillah A; Edwards T; Burr SE; Hart JD; Joof H; Laye M; Makalo P; Manjang A; Molina S; Sarr-Sissoho I; Quinn TC; Lietman T; Holland MJ; Mabey D; West SK; Bailey R;
    PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.